Search

Lakshmi Sarada Channavajjala

Examiner (ID: 456, Phone: (571)272-0591 , Office: P/1611 )

Most Active Art Unit
1611
Art Unit(s)
1615, 1611
Total Applications
1737
Issued Applications
722
Pending Applications
210
Abandoned Applications
818

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12022123 [patent_doc_number] => 20170312222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'Taste-Masked Formulations of Raltegravir' [patent_app_type] => utility [patent_app_number] => 15/652658 [patent_app_country] => US [patent_app_date] => 2017-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10496 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15652658 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/652658
Taste-Masked Formulations of Raltegravir Jul 17, 2017 Abandoned
Array ( [id] => 12157194 [patent_doc_number] => 20180028459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'METHOD OF PRODUCING TRANSDERMAL ABSORPTION SHEET' [patent_app_type] => utility [patent_app_number] => 15/650981 [patent_app_country] => US [patent_app_date] => 2017-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11050 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15650981 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/650981
METHOD OF PRODUCING TRANSDERMAL ABSORPTION SHEET Jul 16, 2017 Abandoned
Array ( [id] => 17095469 [patent_doc_number] => 20210283260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => A CELLULAR SOLID MATERIAL DRUG CARRIER COMPRISING CELLULOSE NANOFIBERS (CNF) WHEREIN THE CELLULAR SOLID MATERIAL COMPRISES CLOSED CELLS [patent_app_type] => utility [patent_app_number] => 16/316192 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14082 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316192 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/316192
A CELLULAR SOLID MATERIAL DRUG CARRIER COMPRISING CELLULOSE NANOFIBERS (CNF) WHEREIN THE CELLULAR SOLID MATERIAL COMPRISES CLOSED CELLS Jul 6, 2017 Abandoned
Array ( [id] => 12000103 [patent_doc_number] => 20170304258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/643201 [patent_app_country] => US [patent_app_date] => 2017-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13372 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15643201 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/643201
Nanoparticle isoflavone compositions and methods of making and using the same Jul 5, 2017 Issued
Array ( [id] => 13151713 [patent_doc_number] => 10092559 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-09 [patent_title] => Abuse resistant pharmaceutical compositions [patent_app_type] => utility [patent_app_number] => 15/626268 [patent_app_country] => US [patent_app_date] => 2017-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14724 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15626268 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/626268
Abuse resistant pharmaceutical compositions Jun 18, 2017 Issued
Array ( [id] => 13076955 [patent_doc_number] => 10058531 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-08-28 [patent_title] => Dosage delivery film [patent_app_type] => utility [patent_app_number] => 15/611581 [patent_app_country] => US [patent_app_date] => 2017-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8209 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611581 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/611581
Dosage delivery film May 31, 2017 Issued
Array ( [id] => 12862381 [patent_doc_number] => 20180179301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-28 [patent_title] => Method of Preparing Oxidized Starch Haemostatic Material [patent_app_type] => utility [patent_app_number] => 15/607561 [patent_app_country] => US [patent_app_date] => 2017-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4060 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 285 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15607561 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/607561
Method of preparing oxidized starch haemostatic material May 28, 2017 Issued
Array ( [id] => 12029476 [patent_doc_number] => 20170319575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS' [patent_app_type] => utility [patent_app_number] => 15/606112 [patent_app_country] => US [patent_app_date] => 2017-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13873 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606112 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/606112
Tamper-resistant pharmaceutical compositions of opioids and other drugs May 25, 2017 Issued
Array ( [id] => 11954573 [patent_doc_number] => 20170258724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-14 [patent_title] => 'METHOD OF BORON NITRIDE NANOPARTICLE FABRICATION FOR ANTITUMOR DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 15/600510 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3710 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600510 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/600510
METHOD OF BORON NITRIDE NANOPARTICLE FABRICATION FOR ANTITUMOR DRUG DELIVERY May 18, 2017 Abandoned
Array ( [id] => 12143672 [patent_doc_number] => 09877908 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-30 [patent_title] => 'Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives' [patent_app_type] => utility [patent_app_number] => 15/588485 [patent_app_country] => US [patent_app_date] => 2017-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13923 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15588485 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/588485
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives May 4, 2017 Issued
Array ( [id] => 17944238 [patent_doc_number] => 20220331255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => Solid Dosage Form [patent_app_type] => utility [patent_app_number] => 16/097112 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33965 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097112 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/097112
Solid Dosage Form Apr 27, 2017 Abandoned
Array ( [id] => 13035377 [patent_doc_number] => 10039801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-07 [patent_title] => Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use [patent_app_type] => utility [patent_app_number] => 15/487731 [patent_app_country] => US [patent_app_date] => 2017-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 29 [patent_no_of_words] => 24389 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487731 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/487731
Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use Apr 13, 2017 Issued
Array ( [id] => 11713533 [patent_doc_number] => 20170182032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS' [patent_app_type] => utility [patent_app_number] => 15/457153 [patent_app_country] => US [patent_app_date] => 2017-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9275 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15457153 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/457153
ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS Mar 12, 2017 Abandoned
Array ( [id] => 14975439 [patent_doc_number] => 10441605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-15 [patent_title] => Oral cholestyramine formulation and use thereof [patent_app_type] => utility [patent_app_number] => 15/449781 [patent_app_country] => US [patent_app_date] => 2017-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 10168 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449781 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/449781
Oral cholestyramine formulation and use thereof Mar 2, 2017 Issued
Array ( [id] => 14975437 [patent_doc_number] => 10441604 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-15 [patent_title] => Cholestyramine pellets and methods for preparation thereof [patent_app_type] => utility [patent_app_number] => 15/449645 [patent_app_country] => US [patent_app_date] => 2017-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4772 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449645 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/449645
Cholestyramine pellets and methods for preparation thereof Mar 2, 2017 Issued
Array ( [id] => 12724234 [patent_doc_number] => 20180133245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-17 [patent_title] => Impact of electrolytes on tumors and various diseases [patent_app_type] => utility [patent_app_number] => 15/449807 [patent_app_country] => US [patent_app_date] => 2017-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 228 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449807 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/449807
Impact of electrolytes on tumors and various diseases Mar 2, 2017 Abandoned
Array ( [id] => 14697495 [patent_doc_number] => 10376469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-13 [patent_title] => Microspheres containing therapeutic agents and related methods of use [patent_app_type] => utility [patent_app_number] => 15/436451 [patent_app_country] => US [patent_app_date] => 2017-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9634 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15436451 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/436451
Microspheres containing therapeutic agents and related methods of use Feb 16, 2017 Issued
Array ( [id] => 13925827 [patent_doc_number] => 20190046429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-14 [patent_title] => DERMAL FILLER COMPOSED OF MACROPOROUS CHITOSAN MICROBEADS AND CROSS-LINKED HYALURONIC ACID [patent_app_type] => utility [patent_app_number] => 16/077341 [patent_app_country] => US [patent_app_date] => 2017-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9705 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077341 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/077341
DERMAL FILLER COMPOSED OF MACROPOROUS CHITOSAN MICROBEADS AND CROSS-LINKED HYALURONIC ACID Feb 8, 2017 Abandoned
Array ( [id] => 11647858 [patent_doc_number] => 20170143759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-25 [patent_title] => 'PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/399208 [patent_app_country] => US [patent_app_date] => 2017-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20158 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15399208 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/399208
PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF Jan 4, 2017 Abandoned
Array ( [id] => 12252962 [patent_doc_number] => 09925091 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-27 [patent_title] => 'Combination SIS and vacuum bandage and method' [patent_app_type] => utility [patent_app_number] => 15/398419 [patent_app_country] => US [patent_app_date] => 2017-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 4475 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398419 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/398419
Combination SIS and vacuum bandage and method Jan 3, 2017 Issued
Menu